Kyriaki Kosidou1, Christina Dalman1, Linnea Widman1, Stefan Arver2, Brian K Lee3, Cecilia Magnusson1, Renee M Gardner4. 1. Centre for Epidemiology and Community Medicine, Stockholm County Council, Karolinska Institutet, Stockholm, Sweden; Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden. 2. Division of Public Health Epidemiology, and Department of Medicine, Karolinska Institutet, Stockholm, Sweden. 3. Department of Epidemiology and Biostatistics, Drexel University School of Public Health, Philadelphia, Pennsylvania; A.J. Drexel Autism Institute, Philadelphia, Pennsylvania. 4. Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden. Electronic address: renee.gardner@ki.se.
Abstract
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is the most common childhood neurodevelopmental disorder, and boys are two to three times more likely to develop ADHD. Maternal polycystic ovary syndrome (PCOS), a common metabolic disorder associated with excess circulating androgens, has been associated with increased risk for autism spectrum disorder in the offspring. In this study, we aimed to investigate whether maternal PCOS increases the risk for ADHD in the offspring. METHODS: We conducted a matched case-control study using health and population data registers for all children born in Sweden from 1984 to 2008. Maternal PCOS was defined by ICD-coded register diagnosis. The outcome of ADHD was defined as an ICD-coded register diagnosis of ADHD and/or registered prescription of medications to treat ADHD. A total of 58,912 ADHD cases (68.8% male) were identified and matched to 499,998 unaffected controls by sex and birth month and year. RESULTS: Maternal PCOS increased the odds of offspring ADHD by 42% after adjustment for confounders (odds ratio [OR], 1.42; 95% confidence interval [CI], 1.26-1.58). Exclusion of ADHD cases with comorbid autism spectrum disorder attenuated but did not explain the relationship (OR, 1.34; 95% CI, 1.18-1.52). The risk was somewhat elevated for ADHD with comorbid autism spectrum disorder (OR, 1.76; 95% CI, 1.37-2.26). The risk for ADHD was higher among obese mothers with PCOS (OR, 1.68; 95% CI, 1.31-2.17) and was highest among obese mothers with PCOS and other features of metabolic syndrome (OR, 2.59; 95% CI, 1.02-6.58). CONCLUSIONS: This study provides evidence that maternal PCOS may subtly influence the neurodevelopment of the offspring, resulting in increased risk for neurodevelopmental disorders such as ADHD.
BACKGROUND:Attention-deficit/hyperactivity disorder (ADHD) is the most common childhood neurodevelopmental disorder, and boys are two to three times more likely to develop ADHD. Maternal polycystic ovary syndrome (PCOS), a common metabolic disorder associated with excess circulating androgens, has been associated with increased risk for autism spectrum disorder in the offspring. In this study, we aimed to investigate whether maternal PCOS increases the risk for ADHD in the offspring. METHODS: We conducted a matched case-control study using health and population data registers for all children born in Sweden from 1984 to 2008. Maternal PCOS was defined by ICD-coded register diagnosis. The outcome of ADHD was defined as an ICD-coded register diagnosis of ADHD and/or registered prescription of medications to treat ADHD. A total of 58,912 ADHD cases (68.8% male) were identified and matched to 499,998 unaffected controls by sex and birth month and year. RESULTS:Maternal PCOS increased the odds of offspring ADHD by 42% after adjustment for confounders (odds ratio [OR], 1.42; 95% confidence interval [CI], 1.26-1.58). Exclusion of ADHD cases with comorbid autism spectrum disorder attenuated but did not explain the relationship (OR, 1.34; 95% CI, 1.18-1.52). The risk was somewhat elevated for ADHD with comorbid autism spectrum disorder (OR, 1.76; 95% CI, 1.37-2.26). The risk for ADHD was higher among obese mothers with PCOS (OR, 1.68; 95% CI, 1.31-2.17) and was highest among obese mothers with PCOS and other features of metabolic syndrome (OR, 2.59; 95% CI, 1.02-6.58). CONCLUSIONS: This study provides evidence that maternal PCOS may subtly influence the neurodevelopment of the offspring, resulting in increased risk for neurodevelopmental disorders such as ADHD.
Authors: Griffith A Bell; Rajeshwari Sundaram; Sunni L Mumford; Hyojun Park; James Mills; Erin M Bell; Miranda Broadney; Edwina H Yeung Journal: Hum Reprod Date: 2018-07-01 Impact factor: 6.918
Authors: Rebecca H Bitsko; Joseph R Holbrook; Brenna O'Masta; Brion Maher; Audrey Cerles; Kayla Saadeh; Zayan Mahmooth; Laurel M MacMillan; Margaret Rush; Jennifer W Kaminski Journal: Prev Sci Date: 2022-03-18
Authors: Deborah J Watkins; John D Meeker; Marcela Tamayo-Ortiz; Brisa N Sánchez; Lourdes Schnaas; Karen E Peterson; Martha María Téllez-Rojo Journal: Environ Res Date: 2021-02-25 Impact factor: 6.498
Authors: Drew B Day; Brent R Collett; Emily S Barrett; Nicole R Bush; Shanna H Swan; Christina Wang; Sheela Sathyanarayana Journal: Psychoneuroendocrinology Date: 2019-12-24 Impact factor: 4.693
Authors: Michael V Lombardo; Bonnie Auyeung; Tiziano Pramparo; Amélie Piton; Simon Baron-Cohen; Angélique Quartier; Jérémie Courraud; Rosemary J Holt; Jack Waldman; Amber N V Ruigrok; Natasha Mooney; Richard A I Bethlehem; Meng-Chuan Lai; Prantik Kundu; Edward T Bullmore; Jean-Louis Mandel Journal: Mol Psychiatry Date: 2018-08-13 Impact factor: 15.992